RECRUITING

Vapocoolant Spray to Reduce Pain With Nexplanon Insertion

Description

The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.

Study Overview

Study Details

Study overview

The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.

Topical Vapocoolant to Reduce Pain With Nexplanon Insertion: A Randomized Controlled Trial

Vapocoolant Spray to Reduce Pain With Nexplanon Insertion

Condition
Reducing Pain With Nexplanon Implant Insertion
Intervention / Treatment

-

Contacts and Locations

Honolulu

Queens Medical Center POB 2 Suite 402, Honolulu, Hawaii, United States, 96813

Honolulu

Queens Medical Center POB1 Clinic 1004, Honolulu, Hawaii, United States, 96813

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * At least 14 years or older
  • * Undergoing an etonogestrel implant insertion in the arm in POB1 Suite 1004 or POB2 Suite 402
  • * English speaking
  • * Able and willing to sign the informed consent form and agree to terms of the study
  • * Required or requested narcotics, anxiolytics, IV sedation, or general anesthesia for the procedure
  • * Known previous exposure to vapocoolant spray
  • * Nexplanon removal and reinsertion in same visit
  • * Contraindications to vapocoolant spray components (ethyl chloride and 1,1,1,3,3-pentafluoropropane/1,1,1,2-tetrafluroethane)
  • * Unable to provide written, informed consent in English

Ages Eligible for Study

14 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Queen's Medical Center,

Study Record Dates

2026-05-01